aTyr Pharma Stock Price. Everything You Need To Know About The aTyr Pharma Stock!
aTyr Pharma, Inc. is a biopharmaceutical company based in San Diego, California, that specializes in the discovery and development of medicines based on novel biological pathways. The company currently employs 65 full-time employees and went public on May 7th, 2015.
The Company’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate that targets neuropilin-2 (NRP2) to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a mechanism of action for potentially treating lung inflammation and fibrosis, with its lead indication for pulmonary sarcoidosis, a major form of interstitial lung disease.
aTyr Pharma, Inc.’s other product candidates include ATYR2810, NRP2 mAbs, AARS and DARS. ATYR2810 is a product candidate from its NRP2 antibody program, and the company is also advancing its preclinical pipeline of tRNA synthetases and NRP2. In addition, aTyr Pharma, Inc. has also advanced its preclinical pipeline of NRP2 targeting antibody candidates.
It is essential to conduct research before investing in aTyr Pharma, Inc.’s shares or stocks share price today. While the company’s innovative approach to medicine makes it an attractive investment option for many, it is crucial to stay up-to-date with the latest industry trends and insights to make well-informed investment decisions that align with your financial goals.
In conclusion, aTyr Pharma, Inc. is a reputable biopharmaceutical company that specializes in the discovery and development of medicines based on novel biological pathways. With its primary focus on efzofitimod and other product candidates, the company is committed to resolving chronic inflammation that can lead to fibrosis. Remember, staying informed about the company’s stock price, market cap, and industry trends is essential for those interested in investing in the biotech sector.
aTyr Pharma Stock Price. Everything You Need To Know About The aTyr Pharma Stock! performance
- Employees 65
- Company HQ San Diego
- Website https://www.atyrpharma.com/
- LIFE Asset Type Common Stock
- LIFE Market Capitalization 108.7M
- Earnings Per Share -0.94
- Dividends Per Share None
- Dividend Date 2019-07-01
- Quarterly Earnings Growth 0
Investors from Malaysia, Thailand, Indonesia, and Vietnam seeking to explore investment opportunities have a chance to tap into the potential of aTyr Pharma. As a content marketing expert at Zorion, an esteemed investment platform, we provide valuable investment insights and recommendations to help retail investors make informed decisions. aTyr Pharma, a pioneering biotech company, is an excellent stock choice for investors interested in the healthcare sector. By investing in aTyr Pharma, investors can participate in the company’s innovative approach to discovering and developing new medicines based on physiological modulators. Zorion ensures investors have access to resources and educational materials to enhance their investment knowledge, making it easier for them to invest in aTyr Pharma from Malaysia, Thailand, Indonesia, and Vietnam.
